New Director Brings Extensive Medical Device Industry Leadership and Technology Experience to Integer Board PLANO, Texas, July 10, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced it has appointed Michael Coyle to its Board of Directors. Coyle brings more than 40 years of leadership in the medical... Read More

PLANO, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on July 1, 2025, and ending at the close of... Read More

PLANO, Texas, June 26, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it will webcast its conference call discussing financial results and business highlights for the second quarter ended June 27, 2025, on Thursday, July 24, 2025, at 8 a.m. CT / 9 a.m. ET. Other forward-looking and material information may also be discussed during this call. The company will issue a news release... Read More

PLANO, Texas, June 03, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced participation in the 2025 Truist Securities MedTech Conference, to be held June 17, 2025, in Boston. Members of the Integer executive leadership team will participate in a fireside chat on Tuesday, June 17, at 10:40 a.m. ET. A live webcast of... Read More

PLANO, Texas, April 29, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation in the 2025 Bank of America Securities Health Care Conference, to be held May 13-15, 2025, in Las Vegas. Members of the Integer executive leadership team will participate in a fireside chat on Wednesday, May 14, at 10:00... Read More

Joseph Dziedzic to retire as President and CEO Payman Khales appointed President and CEO effective October 24, 2025 PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization, today announced that Joseph Dziedzic will retire as President and Chief Executive Officer and will step down from the Board of Directors,... Read More

Strong start to the year with 1Q25 financial results Reiterating 2025 sales and adjusted operating income outlook; raising adjusted EPS outlook PLANO, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 28, 2025. First Quarter 2025 Highlights (compared to First Quarter 2024, except as noted) Sales increased 7% to $437 million, with... Read More

PLANO, Texas, April 11, 2025 (GLOBE NEWSWIRE) - - Integer Holdings Corporation (NYSE: ITGR), a leading contract development and manufacturing organization, issued a statement on the impact of tariffs on its business given the recent extraordinary developments regarding trade policies. “We continue to estimate an impact of $1 to $5 million on full year adjusted operating income, consistent with previous communications. This... Read More

PLANO, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on April 1, 2025, and ending at the close of... Read More

PLANO, Texas, March 27, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) announced today that it plans to release financial and operational results for first quarter 2025 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 24, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material... Read More

Strategic transaction to create revolver capacity Immediately accretive to 2025 adjusted earnings on meaningfully lower interest expense PLANO, Texas, March 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company”) (NYSE: ITGR), a leading medical device contract development and manufacturing organization, announces the closing of its offering of $1.0 billion aggregate principal amount of 1.875% convertible... Read More

PLANO, Texas, March 13, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it has priced an offering of $875.0 million aggregate principal amount of 1.875% convertible senior notes due 2030 (the “Convertible Notes”). The offering was upsized from the previously announced offering size of $750.0 million aggregate principal amount of Convertible Notes. The Company... Read More

PLANO, Texas, March 12, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it intends to offer, subject to market and other conditions, $750.0 million aggregate principal amount of its convertible senior notes due 2030 (the “Convertible Notes”). The Company also intends to grant to the initial purchasers of the Convertible Notes an option to purchase up to an... Read More

Strong 4Q and Full Year sales and profit increase versus last year Expect 8% to 10% sales growth in 2025 with expanding margins PLANO, Texas, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading contract development and manufacturing organization, today announced results for the three and twelve months ended December 31, 2024. Unless otherwise stated, all results and comparisons are from... Read More

PLANO, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced participation at the following upcoming investor conferences. Integer will participate at the 2025 Raymond James & Associates’ 46th Annual Institutional Investor Conference, to be held March 3-5, 2025, in Orlando, Florida.... Read More

PLANO, Texas, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 4 – 6, 2025, at the Anaheim Convention Center in Anaheim, California. Integer welcomes visitors to booth #1439 to learn more about the company’s... Read More

PLANO, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, will join global medtech leaders and innovators in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting in Orlando, Florida, from Jan. 30 – Feb. 1, 2025. NANS attendees are invited to visit booth #213 to... Read More

PLANO, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full year 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, February 20, 2025. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and... Read More

PLANO, Texas, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on January 1, 2025, and ending at the close of... Read More

PLANO, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), will participate in the Piper Sandler 36 th Annual Healthcare Conference, to be held Dec. 3 – 5 in New York City. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present Tuesday, Dec. 3, 2024, at 10:30 a.m. EST. The... Read More

PLANO, Texas, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced the completion of the previously announced sale of its Electrochem business to Ultralife Corporation for $50 million in cash. Integer will use the proceeds from the sale to pay down outstanding debt. “With the divestiture of... Read More

PLANO, Texas, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced that Payman Khales will assume the newly created role of Chief Operating Officer during the first quarter of 2025. Andrew Senn will take Mr. Khales’ place as the President, Cardio & Vascular at the same time. Mr. Khales joined the... Read More

Continued strong performance with 3Q24 financial results Raising midpoint of 2024 operating profit and EPS outlook PLANO, Texas, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three and nine months ended September 27, 2024. Our previously announced sale of the Electrochem business for $50 million in cash remains on track and is expected to close later this month.... Read More

PLANO, Texas, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on October 1, 2024, and ending at the close of... Read More

NEWARK, N.Y., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has signed a stock purchase agreement to acquire all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) to include its state-of-the-art ISO certified technology and manufacturing facility for $50.0 million in cash from Integer Holdings Corporation (NYSE: ITGR), subject to customary working capital adjustments. The transaction... Read More

PLANO, Texas, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced it has entered into an agreement to divest its Electrochem business, which focuses on non-medical applications for the energy, military and environmental sectors, to Ultralife Corporation (NASDAQ: ULBI). Ultralife is acquiring... Read More

PLANO, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for third quarter 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, October 24, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material... Read More

PLANO, Texas, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today formally announced the completion of its facility expansions in Ireland. The occasion was marked with the official opening of Integer’s new European medical device innovation and manufacturing center in Galway, Ireland, on Sept. 20. This... Read More

PLANO, Texas, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation at the Wells Fargo 2024 Healthcare Conference, to be held Sept. 4 – 6, 2024, in Boston. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Wednesday, Sept. 4, at 2:15 pm EDT. A live... Read More

Report Highlights Integer’s Commitment to Minimizing Environmental Footprint, Maximizing Positive Global Impact and Enhancing the Lives of Patients Worldwide PLANO, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced the release of its first environmental, social and governance (ESG)... Read More

Continued strong performance with 2Q24 financial results Raising full year 2024 profit outlook PLANO, Texas, July 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended June 28, 2024. Second Quarter 2024 Highlights (compared to Second Quarter 2023, except as noted) Sales increased 9% to $436 million, with organic growth of 5%. GAAP net income increased $7... Read More

PLANO, Texas, July 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (“Integer” or the “Company”), a leading medical device contract development and manufacturing organization, today notified holders of its 2.125% Convertible Senior Notes due 2028 (the “Notes”) that the Notes are convertible, at the option of the holders (the “Conversion Option”) beginning on July 1, 2024, and ending at the close of... Read More

PLANO, Texas, June 27, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2024 at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material... Read More

PLANO, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced participation at the 2024 Truist Securities MedTech Conference, to be held June 17 – 18, 2024, in Boston. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present as part of a fireside chat on... Read More

PLANO, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), will join medtech industry leaders around the world in exhibiting at Heart Rhythm 2024, a Heart Rhythm Society (HRS) educational event and exhibition in Boston from May 16 – 19, 2024. HRS attendees are invited to visit Integer at booth #753 to learn... Read More

PLANO, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced participation in the 2024 Bank of America Securities Healthcare Conference, to be held May 14 – 16, 2024, in Las Vegas. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Tuesday, May 14, at 10:40... Read More

Strong start to the year with 1Q24 financial results Reiterate 2024 financial outlook PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended March 29, 2024. First Quarter 2024 Highlights (compared to First Quarter 2023, except as noted) Sales increased 10% to $415 million, with organic growth of 6%. GAAP net income increased $7 million to... Read More

PLANO, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 25, 2024. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material... Read More

PLANO, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 11:15 a.m. ET on Tuesday, March 19, 2024. A live webcast of the presentation will be accessible under “News & Events” on the Investor Relations section of the... Read More

Strong 4Q and Full Year sales and profit increase versus last year Expect 9% to 11% sales growth in 2024 with expanding margins PLANO, Texas, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve months ended December 31, 2023. Unless otherwise stated, all results and comparisons are from continuing... Read More

Attendees Invited to Visit Integer at Booth #1439 PLANO, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leader in medical device outsource manufacturing, will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 6-8, 2024, at the Anaheim Convention Center in Anaheim, California. Integer welcomes visitors to booth #1439 to learn more about the company’s... Read More

PLANO, Texas, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech leaders and innovators around the world in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace in Las Vegas from Jan. 18 – 21, 2024. During NANS, attendees are invited to visit booth #127 to learn more about Integer’s... Read More

Preliminary unaudited full year 2023 sales increase 16% versus 2022 Acquisition adds highly differentiated micro machining capability in high growth end markets Schedules conference call for fourth quarter and full year 2023 results PLANO, Texas, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced fourth quarter 2023 preliminary... Read More

PLANO, Texas, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference to be held in San Francisco from Jan 8-11, 2024. Joseph Dziedzic, President and Chief Executive Officer, is scheduled to present on Wednesday, Jan. 10, 2024, at 4:30 p.m. PT (7:30 p.m. ET). A live webcast of the presentation will be accessible... Read More

PLANO, Texas, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming Piper Sandler 35 th Annual Healthcare Conference to be held in New York City from Nov. 28–30, 2023. Joseph Dziedzic, President and Chief Executive Officer, is scheduled to present on Wednesday, Nov. 29, 2023, at 10:00 a.m. EST. The presentation will be accessible via a live webcast . The link... Read More

PLANO, Texas, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer and a complete partner in innovation, will exhibit at Compamed 2023 from November 13-16, in Düsseldorf, Germany. Integer can be found in Hall 8b / N29. During Compamed, Integer looks forward to connecting with medical device OEMs and start-ups to discuss its comprehensive suite of... Read More

Delivered strong performance with 3Q23 financial results Increasing full year 2023 outlook PLANO, Texas, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended September 29, 2023. Third Quarter 2023 Highlights (compared to Third Quarter 2022, except as noted) Sales increased 18% to $405 million, with... Read More

PLANO, Texas, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators around the world in exhibiting at the MD&M Minneapolis Exposition from Oct. 10 – 11, 2023, at the Minneapolis Convention Center. Attendees are invited to visit Integer at booth #3011 to learn more about Integer’s range of innovative... Read More

PLANO, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for third quarter 2023, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, October 26, 2023. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material... Read More

PLANO, Texas, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, Diron Smith, Vice President and Interim Chief Financial Officer, and Andrew Senn, Senior Vice President, Strategy, Business Development & Investor Relations, are scheduled to participate at the 2023 Wells Fargo Healthcare Conference on Thursday, September 7, 2023... Read More

Continued strong performance with 2Q23 financial results Increasing full year 2023 outlook PLANO, Texas, July 27, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended June 30, 2023. Second Quarter 2023 Highlights (compared to Second Quarter 2022, except as noted) Sales increased 14% to $400 million, with organic... Read More

PLANO, Texas, June 29, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for second quarter 2023, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, July 27, 2023. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material... Read More

PLANO, Texas, June 15, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, and Andrew Senn, Senior Vice President, Strategy, Business Development, and Investor Relations, will participate in Citi's 2023 European Healthcare Conference, which will be held at the Citigroup Centre, 33 Canada Square, London, England, beginning at 8:00 a.m.... Read More

PLANO, Texas, May 02, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) today announced participation in the upcoming Bank of America Securities 2023 Healthcare Conference in Las Vegas, Nevada. Joseph Dziedzic, President and Chief Executive Officer, and Jason Garland, Executive Vice President and Chief Financial Officer, are scheduled to present on Wednesday, May 10, 2023, at 5:00 p.m. Pacific Time (8:00... Read More

Strong start to the year with 1Q23 financial results Executing strategy to accelerate growth PLANO, Texas, April 27, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three months ended March 31, 2023. First Quarter 2023 Highlights (compared to First Quarter 2022, except as noted) Sales increased 22% to $379 million, with... Read More

PLANO, Texas, March 30, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2023, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 27, 2023. Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss these results. Other forward-looking and material... Read More

PLANO, Texas, March 09, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that Joe Dziedzic, President and Chief Executive Officer, and Jason Garland, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum at 10:30am ET on Tuesday, March 21, 2023. Interested parties may access a... Read More

Strong sales growth over last year of 19% in 4Q22 and 13% for the full year Expect 7% to 9% sales growth in 2023 with expanding margins PLANO, Texas, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve months ended December 31, 2022. Unless otherwise stated, all results and comparisons are from continuing... Read More

Strategic transaction to meaningfully reduce interest expense Immediately earnings accretive in 2023 PLANO, Texas, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR) (the “Company”), a leading medical device outsource manufacturer, announces the closing of its offering of $500 million aggregate principal amount of 2.125% convertible senior notes due 2028 (the “Notes”). In response to strong investor... Read More

PLANO, Texas, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators around the world in exhibiting at the MD&M West Exposition at the Anaheim Convention Center in Anaheim, Calif., from Feb. 7 – 9, 2023. Attendees are invited to visit Integer at booth #1759 to learn more about Integer’s range of... Read More

PLANO, Texas, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it has priced an offering of $435 million aggregate principal amount of 2.125% convertible senior notes due 2028 (the “Convertible Notes”). The offering was upsized from the previously announced offering size of $375 million aggregate principal amount of Convertible Notes. The Company... Read More

PLANO, Texas, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (the “Company,” “Integer”) (NYSE: ITGR) today announced that it intends to offer, subject to market and other conditions, $375 million aggregate principal amount of its convertible senior notes due 2028 (the “Convertible Notes”). The Company also intends to grant to the initial purchasers of the Convertible Notes an option to purchase up to an... Read More

Preliminary fourth quarter 2022 sales increase of 18% to 19% versus 2021 Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call PLANO, Texas, Jan. 30, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource manufacturer, announces preliminary financial results for the fourth quarter and full year ended December 31, 2022. Unless otherwise stated, all... Read More

PLANO, Texas, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will exhibit at the 26th North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace Convention Center in Las Vegas, Nevada, from Jan. 12 – 14, 2023, joining medtech leaders and innovators from around the world. Attendees are invited to visit Integer at booth... Read More